Antipsychotic Drugs Market To Reach $32.24 Billion By 2033

October 2025 | Report Format: Electronic (PDF)

Antipsychotic Drugs Market Growth & Trends

The global antipsychotic drugs market size is expected to reach USD 32.24 billion by 2033, registering a CAGR of 6.1% from 2025 to 2033, according to a new report by Grand View Research, Inc. The continuous development of better next-generation products to overcome adverse effects and unwanted reactions of existing products is creating demand for newer products. This factor is anticipated to propel the market.

Rapid growth of antipsychotics can be attributed to the rising prevalence of psychosis and other mental disorders. Governments are focused on creating awareness regarding mental health and psychological illnesses, which is further anticipated to drive the demand for antipsychotics. Government bodies in collaboration with major players conduct social programs to break the stigma related to psychotic disorders that exists in the society.

Adverse effects of antipsychotics, such as insomnia, dry mouth, drowsiness, and blurred vision, are expected to affect the growth by decreasing the level of acceptance in patients. In addition, the possibility of dependency, habit formation, or addiction is affecting the adoption of these drugs.

Established brands such as, Zyprexa lost patent protection in October 2011, followed by Seroquel and Risperdal in 2012, which hampers the market growth for these drugs. Also, the entry of generic versions of these products slowed the growth of the already existing brands.

key Request a free sample copy or view report summary: Antipsychotic Drugs Market Report

Antipsychotic Drugs Market Report Highlights

Schizophrenia accounted for the largest market revenue share of 39.0% in 2024. Schizophrenia is a serious mental illness that impacts a significant number of individuals worldwide
Aripiprazole accounted for the largest revenue share of the antipsychotic drugs market in 2024. The adoption of third-generation products drives the sales in this segment
The second-generation therapeutic class accounted for the largest revenue share of the antipsychotic drugs industry in 2024. The growth of this segment can be attributed to the presence of several second-generation medications available in the market
The retail pharmacies segment dominated the market and accounted for the largest share in 2024. Retail pharmacies are easily available to patients and often act as the initial point of contact for individuals requiring prescription medications.
North America dominated the antipsychotic drugs market with the largest revenue share of 37.6% in 2024. Some of the critical factors attributable to the region’s market dominance include the strong prevalence of psychiatric illnesses in the region and the market presence of prominent biopharmaceutical companies.

Antipsychotic Drugs Market Segmentation

Grand View Research has segmented the global antipsychotic drugs market report based on disease, drug, therapeutic class, distribution channel, and region:

Antipsychotic Drugs Disease Outlook (Revenue, USD Million, 2021 - 2033)